Türk Kardiyoloji Derneği Arşivi (Jul 2017)

Familial hypertrophic cardiomyopathy: A case with a new mutation in the MYBPC3 gene

  • Olgu Hallioglu Kilinc,
  • Dilek Giray,
  • Atil Bisgin,
  • Sevcan Tug Bozdogan,
  • Derya Karpuz

DOI
https://doi.org/10.5543/tkda.2016.56267
Journal volume & issue
Vol. 45, no. 5
pp. 450 – 453

Abstract

Read online

Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease with variable clinical features that is inherited as autosomal dominant with variable penetrance. Recent developments in genetics of hereditary cardiomyopathy have not only enlightened many points about pathogenesis, but have also provided great benefit to diagnostic approaches of clinicians. Heterozygous mutation of c3691-3692insTTCA in MYBPC3 gene was identified in a pediatric patient with diagnosis of hypertrophic cardiomyopathy at clinic. Hypertrophy was observed in sister and father of the patient in echocardiography screening, and it was subsequently determined that they also had same mutation. This mutation has not previously been defined and reported previously in the literature as cause of hypertrophic cardiomyopathy.

Keywords